[Balint Seeber] just sent in a small yet timely project he’s been working on: a software radio source block for the Realtek RTL2832U. Now with a cheap USB TV tuner card, you can jump right into ...

Once you’ve amassed this arsenal of software defined radios, you may find yourself needing a way to transport and deploy them. Luckily, [Jay Doscher] has you covered. His latest creation ...

The vertex shader is used to transform the attributes of vertices (points of a triangle) such as color, texture, position and direction from the original color space to the display space.

Antaris™ has unveiled comprehensive software support for the OpenLST software-defined radio, a pivotal tool introduced by ...

Optimising the benefits of instant data sharing among taxpayers and tax administrations necessitates a pragmatic understanding of the challenges and technology required There exists understandable ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

HOUSTON, September 06, 2024--(BUSINESS WIRE)--Vertex Energy, Inc. (NASDAQ:VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality ...

DBS analyst Mark Kong CFA has maintained their neutral stance on VRTX stock, giving a Hold rating yesterday. Mark Kong CFA has given his Hold ...

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than ...

Overstocks, closeouts, hard to find radios & accessories. Call us at 763-488-1555 for all of your communications equipment needs. We feature Motorola, Kenwood, Vertex Standard, Icom, MaCom ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.